Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trialHee Jin Cho(Kyungpook National University), Hyo Song Kim(Yonsei University)Nature CommunicationsJanuary 23, 202410.1038/s41467-024-44875-2Cited by 29SaveCiteExport RISWatch citationsRelated PapersPemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial|ESMO Open|2021|8